| Application no. and date | 13734111.1 (espacenet) (Federated) (European Patent Register), 20130705 | | Patent/reg. no. and date | DK/EP 2869841, 20210825 | | Publication date | 20150513 | | Priority no. and date | WO PCT/EP2012/063196, 20120705 | | EP pub. no. and date |
EP 2869841 20150513 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals SA, Rue de l'Institut 89
1330 Rixensart, BE | | Applicant ref. no. | V350079DKEP | | Inventor | NICOSIA, Alfredo, Via Parco Carelli 70
80123 Naples, IT,
VITELLI, Alessandra, Via GB Niccolini 10
00152 Rome, IT,
CORTESE, Ricardo, GlaxoSmithKline Biologicals SA
Rue de l'Institute 89
1330 Rixensart, BE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/155 (2006.01) , C07K 16/44 (2006.01) , C12N 15/861 (2006.01) , C12N 15/863 (2006.01) | | Title | Hidtil ukendte prime-boosting-regimer, der omfatter immunogene polypeptider kodet af polynukleotider | | Int. application no. | EP2013064286 | | Int. publication no. | WO2014006191 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
